Press Releases

All Releases
View Summary Immune Responses Enhanced and Sustained When PROVENGE® (sipuleucel-T) is Given After Androgen Deprivation Therapy in Biochemically-Recurrent Prostate Cancer
Apr 11, 2014
PDF 15.5 KB Add to Briefcase
View Summary Dendreon Announces Plans to Make PROVENGE® Commercially Available in Europe
Mar 3, 2014
PDF 14.1 KB Add to Briefcase
View Summary Dendreon Announces Fourth Quarter and 2013 Year End Results
Mar 3, 2014
PDF 29.9 KB Add to Briefcase
View Summary Dendreon Announces Webcast Presentation at Cowen and Company Health Care Conference
Feb 20, 2014
PDF 9.4 KB Add to Briefcase
View Summary Dendreon to Host Conference Call on March 3 to Announce Fourth Quarter and Full Year 2013 Financial Results
Feb 14, 2014
PDF 10.5 KB Add to Briefcase
View Summary Dendreon Announces Presentation of PROVENGE® (sipuleucel-T) Data at the 2014 Genitourinary Cancer Symposium (ASCO GU)
Jan 30, 2014
PDF 68.8 KB Add to Briefcase
View Summary Dendreon Announces Preliminary Fourth Quarter 2013 Revenues
Jan 13, 2014
PDF 15.8 KB Add to Briefcase
View Summary Dendreon Announces Change to Presentation Date and Time at J.P. Morgan Healthcare Conference
Jan 9, 2014
PDF 9.5 KB Add to Briefcase
View Summary Dendreon Announces Webcast Presentation at J.P. Morgan Healthcare Conference
Jan 7, 2014
PDF 9.4 KB Add to Briefcase
View Summary Dendreon Announces Webcast Presentation at Deutsche Bank BioFEST Conference
Nov 26, 2013
PDF 9.4 KB Add to Briefcase
View Summary Dendreon Announces Third Quarter 2013 Results
Nov 12, 2013
PDF 28.8 KB Add to Briefcase
View Summary Dendreon to Host Conference Call on November 12 to Announce Third Quarter Financial Results
Oct 7, 2013
PDF 12.8 KB Add to Briefcase
View Summary Dendreon Corporation Announces Presentation of PROVENGE® (sipuleucel-T) Data at the 2013 European Cancer Congress
Sep 27, 2013
PDF 21.0 KB Add to Briefcase
View Summary Dendreon Announces Marketing Authorization for PROVENGE® in the European Union
Sep 17, 2013
PDF 14.5 KB Add to Briefcase
View Summary Dendreon Announces Second Quarter 2013 Results
Aug 8, 2013
PDF 28.7 KB Add to Briefcase
View Summary Dendreon to Host Conference Call on August 8 to Announce Second Quarter Financial Results
Jul 15, 2013
PDF 12.6 KB Add to Briefcase
View Summary Dendreon Receives Positive Opinion for PROVENGE® in the European Union
Jun 28, 2013
PDF 14.7 KB Add to Briefcase
View Summary Dendreon Announces Presentation of PROVENGE® (sipuleucel-T) Data at the 2013 ASCO Annual Meeting
May 31, 2013
PDF 29.7 KB Add to Briefcase
View Summary Dendreon Announces First Quarter 2013 Results
May 9, 2013
PDF 24.9 KB Add to Briefcase
View Summary PROVENGE® (sipuleucel-T) Data Presented at An Annual Scientific Urology Meeting
May 6, 2013
PDF 16.5 KB Add to Briefcase
Showing 1-20 of 433 Page: 1 2 3 4 5 ... 22  Next 20
Add to Briefcase = add release to Briefcase